• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证

International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.

作者信息

Bardhan K D, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H

机构信息

District General Hospital, Rotherham, UK.

出版信息

Digestion. 2007;75 Suppl 1:48-54. doi: 10.1159/000101082. Epub 2007 May 4.

DOI:10.1159/000101082
PMID:17489032
Abstract

BACKGROUND

Reflux Questionnaire (ReQuest), a newly developed gastro-oesophageal reflux disease-sensitive scale, can be used to reliably evaluate the effect of treatment on gastro-oesophageal reflux disease symptoms.

AIM

International validation of this scale, in patients suffering from endoscopy-negative gastro-oesophageal reflux disease.

METHODS

In this open, multicentre and multinational clinical trial 840 endoscopy-negative gastro-oesophageal reflux disease patients received pantoprazole 20 mg daily for 28 days. The long and short versions of ReQuest were completed both in the pre-treatment and treatment phases. For scale development an item reduction analysis was performed. Internal consistency, test-retest reliability and responsiveness were calculated for psychometric analysis. Construct validity was evaluated by comparison with the Gastrointestinal Symptom Rating Scale and the Psychological General Well-being questionnaire by means of correlation coefficients.

RESULTS

Factor analyses confirmed the content validity of both long and short version of ReQuest. Psychometric calculations proved high internal consistency (Cronbach's alpha: 0.9), test-retest reliability [Intraclass Correlation Coefficient: 0.9 (long vs. long) and 0.8 (short vs. short)], and responsiveness (Responsiveness Index 320.3) of the scale, for which also good construct validity was achieved (correlation coefficient: Gastrointestinal Symptom Rating Scale 0.6; Psychological General Well-being -0.4).

CONCLUSION

ReQuest proved valid, reliable, and responsive in this multinational clinical trial to evaluate treatment response in endoscopy-negative gastro-oesophageal reflux disease patients.

摘要

背景

反流问卷(ReQuest)是一种新开发的对胃食管反流病敏感的量表,可用于可靠地评估治疗对胃食管反流病症状的影响。

目的

在患有内镜检查阴性的胃食管反流病患者中对该量表进行国际验证。

方法

在这项开放性、多中心和跨国的临床试验中,840例内镜检查阴性的胃食管反流病患者每天接受20毫克泮托拉唑治疗,持续28天。在治疗前和治疗阶段均完成了ReQuest的长版和短版问卷。为了量表开发,进行了项目简化分析。计算内部一致性、重测信度和反应性以进行心理测量分析。通过与胃肠道症状评定量表和心理总体幸福感问卷的相关系数比较来评估结构效度。

结果

因子分析证实了ReQuest长版和短版的内容效度。心理测量计算证明该量表具有高内部一致性(克朗巴哈系数:0.9)、重测信度[组内相关系数:0.9(长版对长版)和0.8(短版对短版)]和反应性(反应性指数320.3),其结构效度也良好(相关系数:与胃肠道症状评定量表0.6;与心理总体幸福感 -0.4)。

结论

在这项跨国临床试验中,ReQuest被证明在评估内镜检查阴性的胃食管反流病患者的治疗反应方面有效、可靠且具有反应性。

相似文献

1
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Digestion. 2007;75 Suppl 1:48-54. doi: 10.1159/000101082. Epub 2007 May 4.
2
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Aliment Pharmacol Ther. 2004 Oct 15;20(8):891-8. doi: 10.1111/j.1365-2036.2004.02194.x.
3
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.治疗期间胃食管反流病(GERD)症状的评估。第二部分。糜烂性GERD中新型问卷ReQuest的心理测量评估与验证
Digestion. 2007;75 Suppl 1:41-7. doi: 10.1159/000101081. Epub 2007 May 4.
4
Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease.一份针对胃食管反流病患者的简短症状问卷(实践中的请求)的验证
Aliment Pharmacol Ther. 2008 May;27(9):846-51. doi: 10.1111/j.1365-2036.2008.03641.x. Epub 2008 Feb 9.
5
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.治疗期间胃食管反流病症状的评估。第二部分。糜烂性胃食管反流病中新型问卷ReQuest的心理测量评估与验证。
Digestion. 2004;69(4):238-44. doi: 10.1159/000079708. Epub 2004 Jul 12.
6
International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease.糜烂性胃食管反流病患者健康相关生活质量问卷的国际验证
Aliment Pharmacol Ther. 2009 Mar 15;29(6):615-25. doi: 10.1111/j.1365-2036.2008.03922.x. Epub 2008 Dec 19.
7
Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.使用ReQuest对快速治疗成功进行的新型测量:在内镜检查阴性的胃食管反流病患者中,将首次和持续症状缓解作为接受20毫克泮托拉唑或20毫克埃索美拉唑治疗的结果参数。
Digestion. 2007;75 Suppl 1:62-8. doi: 10.1159/000101084. Epub 2007 May 4.
8
Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.开发和验证一种用于胃食管反流病的疾病特异性生活质量问卷:胃食管反流病生活质量问卷(GERD-QOL 问卷)。
Aliment Pharmacol Ther. 2010 Feb 1;31(3):452-60. doi: 10.1111/j.1365-2036.2009.04187.x. Epub 2009 Oct 31.
9
Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.看——但也要听!《请求》:一篇关于一种新的经过验证的评估胃食管反流病(GERD)治疗结果量表的文章。
Digestion. 2007;75 Suppl 1:87-100. doi: 10.1159/000101020. Epub 2007 May 4.
10
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.治疗期间胃食管反流病(GERD)症状的评估。第一部分。新型GERD问卷ReQuest的开发。
Digestion. 2007;75 Suppl 1:32-40. doi: 10.1159/000101080. Epub 2007 May 4.

引用本文的文献

1
Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.超越 Eckardt 评分:食管疾病的患者报告结局测量。
Curr Gastroenterol Rep. 2021 Dec 1;23(12):29. doi: 10.1007/s11894-021-00831-4.
2
An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease.泮托拉唑用于治疗胃食管反流病的最新进展。
Clin Exp Gastroenterol. 2010;3:11-6. doi: 10.2147/ceg.s6355. Epub 2010 Jan 20.